5CASTAIGNE S,LEFEBVRE P, CHOMIERME C, et al. Elf-ecdveness and pharmacorineties of low-dose all-trans retinole acid (25mg/m2) in acute promyelocytic leukemia [M]. Ann Intern Med, 1992(117)229.
6Wang ZY, Chen Z, Differentiation and apoptosis induction therapy in acute promyelocytic Leukemia [ J ]. Lancet Oncology,2000,1:101 - 106.
7WANG ZY,CHEN Z.Differentiation and apoptosis induction therapy in acute promyelocytic leukemia[J].Lancet Oncol,2000,1(10):101-106.
8TALLMAN MS,ANDERSEN JW,SCHIFFER CA,et al.Clinical description of 44 patients with acute promyelocytic leukemia who developed the retinoic acid syndrome[J].Blood,2001,95(1):90-95.
9DE BOTTON S,DOWBRET H,SANZ M,et al.Incidence clinical features and outcome of all trans-retinoic acid syndrome in 413 cases of newly diagnosed acute promyelocytic leukemia[J].Blood.1998,92(8):2712-2718.
10WESTERVELT P,BROWN RA,ADKINS DR,et al.Sudden death among patients with acute promyelocytic leukemia treated with arsenic trioxide[J].Blood,2001,98(2):266-271.
